Ledger.Open graph →
SEC Form D · filed October 17, 2016

Cerulean Pharma Inc

Offering
$1
Sold
$1
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WALTHAM, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (25)

Alan L. Crane · Waltham, MADirectorChristopher D. Guiffre · Waltham, MAExec · DirectorGregg D. Beloff · Waltham, MAExecWilliam H. Rastetter · San Diego, CADirectorSusan L. Kelley · Waltham, MADirectorPaul A. Friedman · Waltham, MADirectorD. B. Israelsen · Alpine, UTDirectorAlejandra V. Carvajal · Waltham, MAExecAdrian D. Senderowicz · Waltham, MAExecDavid R. Parkinson · Waltham, MADirectorWilliam T. Mckee · Waltham, MADirectorDavid R. Walt · Waltham, MADirectorStuart A. Arbuckle · Waltham, MADirectorTom Lue · VAN NUYS, CADirectorChristopher D. Guiffre · Wellesley, MAExec · DirectorGregg D. Beloff · Waltham, MAExecAlejandra V. Carvajal · Waltham, MAExecAdrian D. Senderowicz · Waltham, MAExecDavid R. Parkinson · Waltham, MADirectorWilliam H. Rastetter · San Diego, CADirectorWilliam T. Mckee · Waltham, MADirectorSusan L. Kelley · Waltham, MADirectorDavid R. Walt · Waltham, MADirectorStuart A. Arbuckle · Waltham, MADirectorPaul A. Friedman · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗